SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

CUSIP: P8696W104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Shares, par value US$0.001 per share
Shares outstanding
71,872,133
Total 13F shares
7,195,807
Share change
-568,647
Total reported value
$56,704,456
Price per share
$7.88
Number of holders
30
Value change
-$4,237,018
Number of buys
11
Number of sells
15

Sponsored

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SAIF Advisors Ltd
13F
Company
15%
10,780,820
$76,005,000 30 Sep 2017
13F
ORBIMED ADVISORS LLC
13F
Company
3.7%
2,667,500
$18,806,000 30 Sep 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3%
2,170,200
$15,300,000 30 Sep 2017
13F
GLG Partners LP
13F
Company
1.1%
758,859
$5,342,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.9%
649,848
$4,581,000 30 Sep 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.28%
204,214
$1,439,000 30 Sep 2017
13F
Freedom Investment Management, Inc.
13F
Company
0.21%
149,539
$1,054,000 30 Sep 2017
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
0.14%
99,212
$699,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.11%
78,336
$552,000 30 Sep 2017
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.1%
69,098
$486,000 30 Sep 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.09%
62,000
$436,000 30 Sep 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
58,083
$409,000 30 Sep 2017
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.08%
54,138
$381,000 30 Sep 2017
13F
Walleye Trading LLC
13F
Company
0.07%
49,065
$346,000 30 Sep 2017
13F
CITADEL ADVISORS LLC
13F
Company
0.05%
34,193
$241,000 30 Sep 2017
13F
GROUP ONE TRADING LLC
13F
Company
0.04%
31,261
$220,000 30 Sep 2017
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.04%
30,400
$214,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
27,717
$195,000 30 Sep 2017
13F
CREDIT SUISSE AG/
13F
Company
0.03%
24,739
$174,000 30 Sep 2017
13F
SG Americas Securities, LLC
13F
Company
0.03%
23,141
$163,000 30 Sep 2017
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.03%
18,382
$129,000 30 Sep 2017
13F
Spark Investment Management LLC
13F
Company
0.02%
17,800
$125,000 30 Sep 2017
13F
DLD Asset Management, LP
13F
Company
0.02%
15,000
$106,000 30 Sep 2017
13F
Verity Asset Management, Inc.
13F
Company
0.02%
13,542
$98,000 30 Sep 2017
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
13,200
$93,000 30 Sep 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
12,259
$86,000 30 Sep 2017
13F
Virtu Financial LLC
13F
Company
0.01%
10,119
$71,000 30 Sep 2017
13F
UBS Group AG
13F
Company
0%
2,048
$14,000 30 Sep 2017
13F
IFP Advisors, Inc
13F
Company
0%
2,000
$14,000 30 Sep 2017
13F
SIMPLEX TRADING, LLC
13F
Company
0%
1,771
$12,000 30 Sep 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,250
$9,000 30 Sep 2017
13F
CWM, LLC
13F
Company
0%
500
$4,000 30 Sep 2017
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
300
$2,000 30 Sep 2017
13F
Geneos Wealth Management Inc.
13F
Company
0%
150
$1,000 30 Sep 2017
13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2017

As of 31 Dec 2017, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,195,807 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, GLG Partners LP, DEUTSCHE BANK AG\, Eqis Capital Management, Inc., STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Spark Investment Management LLC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
34
Q4 2017 holders
30
Holder diff
-4
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.